Cardiac and renal inward rectifier potassium channel pharmacology: Emerging tools for integrative physiology and therapeutics

Current Opinion in Pharmacology

Volumn 15, Issue 1, 2014, Pages 7-15

  Swale, Daniel R ^a   Kharade, Sujay V ^a   Denton, Jerod S ^a,b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; CHLOROQUINE; FLECAINIDE; INWARDLY RECTIFYING POTASSIUM CHANNEL; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR1.1; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR2.1; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR2.X; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR4.1; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR7.1; ML 133; N (4 METHOXYBENZYL) 1 (NAPHTHALENE 1 YL)METHANAMINE; NORTRIPTYLINE; PENTAMIDINE; SEROTONIN UPTAKE INHIBITOR; UNCLASSIFIED DRUG; VU 573; VU 590;

CARDIOVASCULAR RISK; CHANNEL GATING; DRUG BINDING SITE; DRUG DESIGN; DRUG SAFETY; DRUG STRUCTURE; DRUG TARGETING; GAIN OF FUNCTION MUTATION; HEART ATRIUM ARRHYTHMIA; HEART DISEASE; HEART FUNCTION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; HUMAN; KCNJ2 GENE; KIDNEY DISEASE; KIDNEY FUNCTION; MOLECULAR PATHOLOGY; NONHUMAN; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SHORT QT SYNDROME;

ANIMALS; HEART DISEASES; HUMANS; KIDNEY DISEASES; MODELS, MOLECULAR; POTASSIUM CHANNELS, INWARDLY RECTIFYING;

EID: 84889806070     PISSN: 14714892     EISSN: 14714973     Source Type: Journal    
DOI: 10.1016/j.coph.2013.11.002     Document Type: Review

References (57)

1. H. Hibino, A. Inanobe, K. Furutani, S. Murakami, I. Findlay, and Y. Kurachi Inwardly rectifying potassium channels: their structure, function, and physiological roles Physiol Rev 90 2010 291 366
2. + channel Kir2.2 at 3.1 A resolution Science 326 2009 1668 1674
3. + channel Nature 371 1994 243 246
4. + channels Science 266 1994 1068 1072 (Pubitemid 24373730)
5. + channels localized to a single negatively charged residue Nature 371 1994 246 249 (Pubitemid 24293022)
6. +channel Kir2.2 Nature 477 2013 495 498
7. 2-channel interaction Eur J Pharmacol 668 2011 72 77
8. 2-channel interaction J Cardiovasc Pharmacol 57 2011 407 415
9. A. Lopez-Izquierdo, D. Ponce-Balbuena, T. Ferrer, A.A. Rodriguez-Menchaca, and J.A. Sanchez-Chapula Thiopental inhibits function of different inward rectifying potassium channel isoforms by a similar mechanism Eur J Pharmacol 638 2010 33 41
10. M.A. van der Heyden, A. Stary-Weinzinger, and J.A. Sanchez-Chapula Inhibition of cardiac inward rectifier currents by cationic amphiphilic drugs Curr Mol Med 13 2013 1284 1298
11. ATP channelopathies: diseases of metabolic homeostasis Pflugers Arch 460 2010 295 306
12. J.M. Anumonwo, and A.N. Lopatin Cardiac strong inward rectifier potassium channels J Mol Cell Cardiol 48 2010 45 54
13. ATP channels: latest twists in a questing tale! J Mol Cell Cardiol 48 2010 71 75
14. W.A. Coetzee Multiplicity of effectors of the cardioprotective agent, diazoxide Pharmacol Ther 140 2 2013 167 175
15. S.G. Priori, S.V. Pandit, I. Rivolta, O. Berenfeld, E. Ronchetti, A. Dhamoon, C. Napolitano, J. Anumonwo, M.R. di Barletta, S. Gudapakkam, and G. Bosi A novel form of short QT syndrome (SQT3) is caused by a mutation in the KCNJ2 gene Circ Res 96 2005 800 807 (Pubitemid 40559520)
16. N.M. Plaster, R. Tawil, M. Tristani-Firouzi, S. Canun, S. Bendahhou, A. Tsunoda, M.R. Donaldson, S.T. Iannaccone, E. Brunt, R. Barohn, and J. Clark Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome Cell 105 2001 511 519 (Pubitemid 32520856)
17. J.A. Sanchez-Chapula, E. Salinas-Stefanon, J. Torres-Jacome, D.E. Benavides-Haro, and R.A. Navarro-Polanco Blockade of currents by the antimalarial drug chloroquine in feline ventricular myocytes J Pharmacol Exp Ther 297 2001 437 445 (Pubitemid 32242605)
18. A.A. Rodriguez-Menchaca, R.A. Navarro-Polanco, T. Ferrer-Villada, J. Rupp, F.B. Sachse, M. Tristani-Firouzi, and J.A. Sanchez-Chapula The molecular basis of chloroquine block of the inward rectifier Kir2.1 channel Proc Natl Acad Sci U S A 105 2008 1364 1368 (Pubitemid 351397059)
19. + channel block by the polyamine spermine J Gen Physiol 125 2005 413 426
20. A. El Harchi, M.J. McPate, Y. Zhang, H. Zhang, and Hancox JC Action potential clamp chloroquine sensitivity of mutant Kir2.S 1 channels responsible for variant 3 short Q.T. syndrome Mol Cell J Cardiol 47 2009 743 747
21. A. Lopez-Izquierdo, D. Ponce-Balbuena, T. Ferrer, F.B. Sachse, M. Tristani-Firouzi, and J.A. Sanchez-Chapula Chloroquine blocks a mutant Kir2.1 channel responsible for short QT syndrome and normalizes repolarization properties in silico Cell Physiol Biochem 24 2009 153 160
22. S.F. Noujaim, J.A. Stuckey, D. Ponce-Balbuena, T. Ferrer-Villada, A. Lopez-Izquierdo, S. Pandit, C.J. Calvo, K.R. Grzeda, O. Berenfeld, J.A. Chapula, and J. Jalife Specific residues of the cytoplasmic domains of cardiac inward rectifier potassium channels are effective antifibrillatory targets FASEB J 24 2010 4302 4312
23. Y.A. Kuryshev, E. Ficker, L. Wang, P. Hawryluk, A.T. Dennis, B.A. Wible, A.M. Brown, J. Kang, X.L. Chen, K. Sawamura, and W. Reynolds Pentamidine-induced long QT syndrome and block of hERG trafficking J Pharmacol Exp Ther 312 2005 316 323 (Pubitemid 40096484)
24. H. Yokoyama, Y. Nakamura, H. Iwasaki, Y. Nagayama, K. Hoshiai, Y. Mitsumori, and A. Sugiyama Effects of acute intravenous administration of pentamidine, a typical hERG-trafficking inhibitor, on the cardiac repolarization process of halothane-anesthetized dogs J Pharmacol Sci 110 2009 476 482
25. T.P. de Boer, L. Nalos, A. Stary, B. Kok, M.J. Houtman, G. Antoons, T.A. van Veen, J.D. Beekman, B.L. de Groot, T. Opthof, and M.B. Rook The anti-protozoal drug pentamidine blocks KIR2.x-mediated inward rectifier current by entering the cytoplasmic pore region of the channel Br J Pharmacol 159 2010 1532 1541
26. S. Pegan, C. Arrabit, W. Zhou, W. Kwiatkowski, A. Collins, P.A. Slesinger, and S. Choe Cytoplasmic domain structures of Kir2.1 and Kir3.1 show sites for modulating gating and rectification Nat Neurosci 8 2005 279 287 (Pubitemid 40300184)
27. K1 inhibition by a new pentamidine analogue Cardiovasc Res 99 2013 203 214
28. H.R. Wang, M. Wu, H. Yu, S. Long, A. Stevens, D.W. Engers, H. Sackin, J.S. Daniels, E.S. Dawson, C.R. Hopkins, and C.W. Lindsley Selective inhibition of the Kir2 family of inward rectifier potassium channels by a small molecule probe: the discovery, SAR, and pharmacological characterization of ML133 ACS Chem Biol 6 2011 845 856
29. C.D. Weaver, D. Harden, S.I. Dworetzky, B. Robertson, and R.J. Knox A thallium-sensitive, fluorescence-based assay for detecting and characterizing potassium channel modulators in mammalian cells J Biomol Screen 9 2004 671 677
30. R. Raphemot, C.D. Weaver, and J.S. Denton High-throughput screening for small-molecule modulators of inward rectifier potassium channels J Vis Exp 71 2013
31. S. Radicke, M. Vaquero, R. Caballero, R. Gomez, L. Nunez, J. Tamargo, U. Ravens, E. Wettwer, and E. Delpon Effects of MiRP1 and DPP6 beta-subunits on the blockade induced by flecainide of Kv4.3/KChIP2 channels Br J Pharmacol 154 2008 774 786 (Pubitemid 351821585)
32. H.M. Himmel, A. Bussek, M. Hoffmann, R. Beckmann, H. Lohmann, M. Schmidt, and E. Wettwer Field and action potential recordings in heart slices: correlation with established in vitro and in vivo models Br J Pharmacol 166 2012 276 296
33. R. Caballero, P. Dolz-Gaiton, R. Gomez, I. Amoros, A. Barana, M. Gonzalez de la Fuente, L. Osuna, J. Duarte, A. Lopez-Izquierdo, I. Moraleda, and E. Galvez Flecainide increases Kir2. 1 currents by interacting with cysteine 311, decreasing the polyamine-induced rectification Proc Natl Acad Sci U S A 107 2010 15631 15636
34. O.A. Pellizzon, L. Kalaizich, L.J. Ptacek, M. Tristani-Firouzi, and M.D. Gonzalez Flecainide suppresses bidirectional ventricular tachycardia and reverses tachycardia-induced cardiomyopathy in Andersen-Tawil syndrome J Cardiovasc Electrophysiol 19 2008 95 97
35. R. Bokenkamp, A.A. Wilde, M.J. Schalij, and N.A. Blom Flecainide for recurrent malignant ventricular arrhythmias in two siblings with Andersen-Tawil syndrome Heart Rhythm 4 2007 508 511 (Pubitemid 46610403)
36. D.A. Calhoun, D. Jones, S. Textor, D.C. Goff, T.P. Murphy, R.D. Toto, A. White, W.C. Cushman, W. White, D. Sica, and K. Ferdinand Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research Hypertension 51 2008 1403 1419
37. + channel, ROMK Nat Genet 14 1996 152 156 (Pubitemid 26338794)
38. W. Ji, J.N. Foo, B.J. O'Roak, H. Zhao, M.G. Larson, D.B. Simon, C. Newton-Cheh, M.W. State, D. Levy, and R.P. Lifton Rare independent mutations in renal salt handling genes contribute to blood pressure variation Nat Genet 40 2008 592 599 (Pubitemid 351601207)
39. L.M. Lewis, G. Bhave, B.A. Chauder, S. Banerjee, K.A. Lornsen, R. Redha, K. Fallen, C.W. Lindsley, C.D. Weaver, and J.S. Denton High-throughput screening reveals a small-molecule inhibitor of the renal outer medullary potassium channel and Kir7.1 Mol Pharmacol 76 2009 1094 1103
40. G. Bhave, B.A. Chauder, W. Liu, E.S. Dawson, R. Kadakia, T.T. Nguyen, L.M. Lewis, J. Meiler, C.D. Weaver, L.M. Satlin, and C.W. Lindsley Development of a selective small-molecule inhibitor of Kir1.1, the renal outer medullary potassium channel Mol Pharmacol 79 2011 42 50
41. H. Tang, S.P. Walsh, Y. Yan, R.K. de Jesus, A. Shahripour, N. Teumelsan, Y. Zhu, S. Ha, K.A. Owens, B.S. Thomas-Fowlkes, and J.P. Felix Discovery of Selective Small Molecule ROMK Inhibitors as Potential New Mechanism Diuretics ACS Medicinal Chemistry Letters 3 2012 367 372
42. J.S. Denton, A.C. Pao, and M. Maduke Invited review. Novel diuretic targets Am J Physiol Renal Physiol 305 7 2013 F931 F942
43. D. Bockenhauer, S. Feather, H.C. Stanescu, S. Bandulik, A.A. Zdebik, M. Reichold, J. Tobin, E. Lieberer, C. Sterner, G. Landoure, and R. Arora Epilepsy, ataxia, sensorineural deafness, tubulopathy, and KCNJ10 mutations N Engl J Med 360 2009 1960 1970
44. U.I. Scholl, M. Choi, T. Liu, V.T. Ramaekers, M.G. Hausler, J. Grimmer, S.W. Tobe, A. Farhi, C. Nelson-Williams, and R.P. Lifton Seizures, sensorineural deafness, ataxia, mental retardation, and electrolyte imbalance (SeSAME syndrome) caused by mutations in KCNJ10 Proc Natl Acad Sci U S A 106 2009 5842 5847
45. O. Zaika, M. Mamenko, O. Palygin, N. Boukelmoune, A. Staruschenko, and O. Pochynyuk Direct inhibition of basolateral Kir4.1/5.1 and Kir4.1 channels in the cortical collecting duct by dopamine Am J Physiol Renal Physiol 2013
46. Y. Ohno, H. Hibino, C. Lossin, A. Inanobe, and Y. Kurachi Inhibition of astroglial Kir4.1 channels by selective serotonin reuptake inhibitors Brain Res 1178 2007 44 51 (Pubitemid 47625356)
47. S. Su, Y. Ohno, C. Lossin, H. Hibino, A. Inanobe, and Y. Kurachi Inhibition of astroglial inwardly rectifying Kir4.1 channels by a tricyclic antidepressant, nortriptyline J Pharmacol Exp Ther 320 2007 573 580 (Pubitemid 46147936)
48. K. Furutani, Y. Ohno, A. Inanobe, H. Hibino, and Y. Kurachi Mutational and in silico analyses for antidepressant block of astroglial inward-rectifier Kir4.1 channel Mol Pharmacol 75 2009 1287 1295
49. J.F. Hejtmancik, X. Jiao, A. Li, Y.V. Sergeev, X. Ding, A.K. Sharma, C.C. Chan, I. Medina, and A.O. Edwards Mutations in KCNJ13 cause autosomal-dominant snowflake vitreoretinal degeneration Am J Hum Genet 82 2008 174 180 (Pubitemid 351726076)
50. K. Ookata, A. Tojo, Y. Suzuki, N. Nakamura, K. Kimura, C.S. Wilcox, and S. Hirose Localization of inward rectifier potassium channel Kir7.1 in the basolateral membrane of distal nephron and collecting duct J Am Soc Nephrol 11 2000 1987 1994
51. C. Derst, J.R. Hirsch, R. Preisig-Muller, E. Wischmeyer, A. Karschin, F. Doring, A. Thomzig, R.W. Veh, E. Schlatter, W. Kummer, and J. Daut Cellular localization of the potassium channel Kir7.1 in guinea pig and human kidney Kidney Int 59 2001 2197 2205 (Pubitemid 32467612)
52. R. Raphemot, D.F. Lonergan, T.T. Nguyen, T. Utley, L.M. Lewis, R. Kadakia, C.D. Weaver, R. Gogliotti, C. Hopkins, C.W. Lindsley, and J.S. Denton Discovery, characterization, and structure-activity relationships of an inhibitor of inward rectifier potassium (Kir) channels with preference for kir2.3, kir3.x, and kir7.1 Front Pharmacol 2 2011
53. + channel with unique pore properties Neuron 20 1998 995 1005 (Pubitemid 28247404)
54. K. Ho, C.G. Nichols, W.J. Lederer, J. Lytton, P.M. Vassilev, M.V. Kanazirska, and S.C. Hebert Cloning and expression of an inwardly rectifying ATP-regulated potassium channel Nature 362 1993 31 38 (Pubitemid 23087286)
55. + channel Am J Physiol 266 Pt 1 1994 C809 C824
56. + channels by fluoxetine (Prozac) Br J Pharmacol 138 2003 1119 1128 (Pubitemid 36459834)
57. R. Raphemot, M.F. Rouhier, C.R. Hopkins, R.D. Gogliotti, K.M. Lovell, R.M. Hine, D. Ghosalkar, A. Longo, K.W. Beyenbach, J.S. Denton, and P.M. Piermarini Eliciting renal failure in mosquitoes with a small-molecule inhibitor of inward-rectifying potassium channels PLoS One 8 2013 e64905